FDA OKs 1st Drug to Treat Duchenne Muscular Dystrophy

MONDAY, Sept. 19, 2016 — The U.S. Food and Drug Administration on Monday granted preliminary approval to the first drug for a rare form of muscular dystrophy.
Exondys 51 (eteplirsen) was granted accelerated approval to treat Duchenne muscular…
Source: Topamax